Industry News
Recognising women in science
Three early-career scientists have been awarded $25,000 one-year fellowships. [ + ]
Senior Cochlear executive Michael Kavanagh named Nanosonics CEO
Nanosonics has tapped senior Cochlear executive Michael Kavanagh to become its next CEO. Kavanagh will take the roles of CEO and president effective 21 October. [ + ]
Animal welfare award for University of Auckland
A collaboration of University of Auckland departments has been recognised for its contribution to reducing and refining the way animals are used for scientific research. [ + ]
A win for the health industry in the Curtin Commercial Innovation Awards
The 2013 Curtin Commercial Innovation Awards winners have been announced, with the three winning entries each having strong or potential applications in the medical industry. [ + ]
Coalition pledges "new approach" to manufacturing
AusBiotech has welcomed 'The Coalition’s Policy to Boost the Competitiveness of Australian Manufacturing' with its support for a "new approach" to manufacturing and a returned focus to Australian industry and SMEs. [ + ]
Australia's first Distinguished Woman in Chemistry or Chemical Engineering
Professor Mary Garson, from the University of Queensland’s (UQ) School of Chemistry and Molecular Biosciences, has become the first Australian to receive a 'Distinguished Woman in Chemistry or Chemical Engineering' award. [ + ]
BioDiem wins third US patent for BDM-I
BioDiem (ASX:BDM) will be granted a US divisional patent covering the use of BDM-I in skin and wound infections caused by different fungi and bacteria. [ + ]
Nexvet picks up a $1.5m CA grant
Commercialisation Australia will award Nexvet a further $1.5m in grant funding to help the company bring its PETisation technology to market. [ + ]
Recipients of 2013 SIEF grants announced
Australia's Chief Scientist, Professor Ian Chubb, this week honoured the 2013 recipients of the Science and Industry Endowment Fund (SIEF) grants to science and scientists. [ + ]
ReCell vitiligo trial hits recruitment goal
A clinical trial involving using Avita Medical’s (ASX:AVH) ReCell Spray-on Skin to treat skin pigment disorders has hit its 10-patient recruitment goal. [ + ]
GTG signs with new US PPO for BREVAGen
Genetic Technologies (ASX:GTG) has arranged for insurance claims for its BREVAGen breast cancer risk test to be adjudicated in-network with an eighth US PPO. [ + ]
Industry invests in university Chair
A new research Chair at the ANU will be funded by Sirtex Medical. [ + ]
Prima cleared to extend cancer trial to Korea
Prima BioMed (ASX:PRR) has received approval to extend its CANVAS cancer vaccine study to South Korea, the first Asian country to be involved in the phase II/III trial. [ + ]
Sitting too much?
Findings of the 12-year AusDiab follow-up study show that Australians aren’t making the lifestyle changes needed to address obesity, high blood pressure and diabetes. [ + ]
Automated identification of 193 human illness initiators
In the US, the Food and Drug Administration has allowed marketing of the bioMérieux VITEK mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans. [ + ]
